We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $767M
1-Year Est. Return 119.71%
This Fund
S&P 500
This Quarter Est. Return
+12.09%
1 Year Est. Return
+119.71%
3 Year Est. Return
+244.81%
5 Year Est. Return
+382.5%
10 Year Est. Return
+2,655.81%
AUM
$683M
AUM Growth
-$101M
Cap. Flow
-$85.4M
Cap. Flow %
-12.5%
Top 10 Hldgs %
52.33%
Holding
153
New
26
Increased
35
Reduced
53
Closed
35

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$20M
2
BIIB icon
Biogen
BIIB
+$11.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.32M
4
ORA icon
Ormat Technologies
ORA
+$5.09M
5
OPK icon
Opko Health
OPK
+$5.01M

Top Sells

Rank Stock Value
1
ESLT icon
Elbit Systems
ESLT
+$29.2M
2
SHPG
Shire pic
SHPG
+$27M
3
AGN
Allergan plc
AGN
+$23M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$12.7M
5
VTRS icon
Viatris
VTRS
+$9.62M

Sector Composition

Rank Sector Weight
1 Healthcare 65.74%
2 Miscellaneous 21.01%
3 Utilities 5.79%
4 Communication Services 2.1%
5 Technology 1.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
101
DELISTED
Strongbridge Biopharma plc.
SBBP
$1.38M 0.2%
+181,818
New +$1.31M
KALV
102
DELISTED
KalVista Pharmaceuticals
KALV
$1.3M 0.19%
25,714
-2,857
-10% -$150K
PRQR icon
103
ProQR Therapeutics
PRQR
$267M
$1.3M 0.19%
+150,000
New +$1.73M
LOXO
104
DELISTED
Loxo Oncology, Inc
LOXO
$1.28M 0.19%
+45,000
New +$1.21M
MNKD icon
105
CALL
MannKind Corp
MNKD
$1.14B
$1.1M 0.16%
+152,000
New +$1.87M
WAB icon
106
Wabtec
WAB
$47.3B
$908K 0.13%
12,761
-9,974
-44% -$797K
ARRY
107
DELISTED
Array Biopharma Inc
ARRY
$907K 0.13%
215,000
-135,000
-39% -$616K
APTV icon
108
Aptiv
APTV
$9.14B
$863K 0.13%
10,065
+915
+10% +$76.5K
ELLO icon
109
Ellomay Capital Ltd
ELLO
$824K 0.12%
95,653
-125,444
-57% -$1.08M
WIX icon
110
WIX.com
WIX
$3.37B
$807K 0.12%
35,460
-22,700
-39% -$511K
CHTR icon
111
Charter Communications
CHTR
$15.5B
$737K 0.11%
4,026
– –
ATXS
112
DELISTED
Astria Therapeutics
ATXS
$640K 0.09%
1,346
-4,112
-75% -$1.97M
EZCH
113
DELISTED
EZCHIP SEMICONDUCTOR LIMITED ORD SHS (IL)
EZCH
$505K 0.07%
+20,447
New +$503K
BMRN icon
114
BioMarin Pharmaceuticals
BMRN
$12.7B
$388K 0.06%
3,700
-121,300
-97% -$12.7M
ATYR
115
aTyr Pharma
ATYR
$36.5M
$358K 0.05%
2,604
-12,327
-83% -$1.75M
GNVC
116
DELISTED
GenVec, Inc.
GNVC
$343K 0.05%
18,650
-17,383
-48% -$332K
ICL icon
117
ICL Group
ICL
$7.16B
$280K 0.04%
+69,083
New +$347K
AOS icon
118
A.O. Smith
AOS
$7.76B
$207K 0.03%
5,400
-15,482
-74% -$584K
AMGN icon
119
Amgen
AMGN
$205B
– –
-50,200
Closed -$6.94M
ASRT
120
DELISTED
Assertio
ASRT
– –
-6,000
Closed -$6.79M
CYTK icon
121
Cytokinetics
CYTK
$9.64B
– –
-372,250
Closed -$2.49M
ESLT icon
122
Elbit Systems
ESLT
$35.1B
– –
-100,618
Closed -$29.2M
FOLD
123
DELISTED
Amicus Therapeutics
FOLD
– –
-310,000
Closed -$4.34M
INSM icon
124
Insmed
INSM
$26.9B
– –
-165,000
Closed -$3.06M
LRMR icon
125
Larimar Therapeutics
LRMR
$404M
– –
-3,333
Closed -$1.28M
3 4
5
6 7

Similar funds

ISWM
Independent Solutions Wealth Management Williamsville, New York $766M AUM 31.53% 1-Year Est. Return
ACP
Albar Capital Partners London, United Kingdom $767M AUM 61.96% 1-Year Est. Return
NIM
Nexus Investment Management Toronto, Ontario, Canada $767M AUM 30.97% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $766M AUM 36.51% 1-Year Est. Return
CBT
Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return
SPIA
Strategic Point Investment Advisors Providence, Rhode Island $767M AUM 17.58% 1-Year Est. Return
CNB
Camden National Bank Camden, Maine $767M AUM 14.32% 1-Year Est. Return
HI
Hendershot Investments Centreville, Virginia $766M AUM 10.81% 1-Year Est. Return

Sphera Funds Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sphera Funds Management held 153 positions worth $683M, down 13% from $784M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sphera Funds Management withdrew a net $85.4M in Q4 2015, closing 35 positions and reducing 53 holdings. Its most notable exit was Elbit Systems, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 59% a quarter earlier, followed by Miscellaneous and Utilities.

Against the trend, Sphera Funds Management opened a new position in Alphabet (Google) Class C worth $5.76M.

  • Sphera Funds Management's largest Q4 2015 buy was Alphabet (Google) Class C: 148,180 shares worth $5.76M.
  • Sphera Funds Management added most to Pfizer in Q4 2015, an estimated $20M increase.
  • Sphera Funds Management's biggest Q4 2015 reduction was Shire pic, cutting an estimated $27M.
  • Sphera Funds Management fully exited Elbit Systems in Q4 2015, selling an estimated $29.2M.
  • Sphera Funds Management's ten largest holdings make up 52% of its $683M portfolio in Q4 2015.
  • Sphera Funds Management opened 26 new positions and closed 35 in Q4 2015.
  • Sphera Funds Management's portfolio value fell 13% quarter-over-quarter to $683M.

Based on Sphera Funds Management's 13F filing for Q4 2015, filed 11 Feb 2016.